Anlotinib+Cadonilimab+PULSAR in Advanced Biliary Tract Cancer

NCT07635290 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Previously Treated, Advanced
Biliary Tract Cancers

Interventions

DRUG: Anlotinib + Cadonilimab
RADIATION: PULSAR

Sponsor

West China Hospital

Collaborators

[object Object]
[object Object]